There are several stocks that passed through the screen and Mirum Pharmaceuticals, Inc. (MIRM) is one of them. Here are the key reasons why this stock is a solid choice for "trend" investing.

In this article, we are going to take a look at where Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM) stands against other best performing mid cap stocks to buy according to analysts. On February 7 ...

Mirum Pharmaceuticals MIRM incurred a loss of 49 cents per share in fourth-quarter 2024, much wider than the Zacks Consensus Estimate of a loss of 27 cents. The company had reported a loss of 66 ...

Joanne Quan, the CHIEF MEDICAL OFFICER of $MIRM ($MIRM), sold 6,969 shares of the company on 01-17-2025 for an estimated $319,598. We received data on the trade from ...

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Mirum Pharmaceuticals (MIRM – Research Report) and AMN Healthcare Services (AMN – Research ...

Shares of MIRM stock opened at $52.50 on Monday. The company’s 50-day moving average price is $46.21 and its 200-day moving average price is $43.13. The company has a current ratio of 3.34 ...

Short interest in Mirum Pharmaceuticals Inc (NASDAQ:MIRM) increased during the last reporting period, rising from 6.57M to 6.61M. This put 15.98% of the company's publicly available shares short.